Lung Cancer
From the Journals
Lung cancer screening rates in U.S. nowhere near goal
Lung cancer screening is effective in reducing mortality, particularly when patients adhere to follow-up recommendations, but too few patients in...
Feature
Convenience, not outcomes may drive robot-assisted surgeries
The sale of robotically assisted surgical devices is expected to reach $14 billion by 2028. The technology is enticing to both surgeons and...
Conference Coverage
Fungal infection can mimic lung cancer metastases
Latest News
Pfizer offers refund if drug ‘doesn’t work’
Although Pfizer claims that its pilot program is a first in the industry, there have been others that are similar.
Latest News
Could your patient benefit? New trials in lung cancer
A rundown of new clinical trials in lung cancer.
From the Journals
Case report: Lung cancer shrinks in patient using CBD oil
“We are unable to conclusively confirm that the tumour regression is due to the patient taking ‘CBD oil,’ ” the authors of the case report wrote...
Conference Recap
Early-Stage NSCLC Highlights From ESMO 2021
Highlights in early NSCLC from ESMO 2021 include data on postoperative radiotherapy, combination regimens in stage III disease, and results with...
Roundtables
The Evolving Role of Biomarker Analysis in the Management of Advanced/Metastatic NSCLC
Conference Coverage
Many patients, doctors unaware of advancements in cancer care
“These patients must be spared the traumatic effects of being handed a death sentence that no longer reflects the current reality,” said Dr....
Conference Coverage
‘Unprecedented’ 3-year sustained survival with lung cancer combo treatment
Recap
Use of Biomarkers to Optimize Treatment of NSCLC
Biomarkers have advanced the field of NSCLC by informing the choice of therapy. Physicians are urged to incorporate genetic profiling at diagnosis...